Innovations in Medicine and Cutting-Edge Research in Melbourne

Day 04 of Road to the Max: Australia took us deeper into the heart of Melbourne’s life sciences sector, where we explored the innovations shaping the future of medicine and therapeutics. Our first stop was the Crown Plaza, where we met with Grant Swart, Australian General Manager of Mayne Pharma — a leading CDMO at the forefront of developing products across a variety of therapeutic areas, including cardiology, dermatology, oncology, and women’s health. Grant shared insights into Mayne Pharma’s mission to improve patient access to prescription medications by offering safer, better, and more accessible medicines.

Not All Heroes Wear Capes

After that, we headed to La Trobe University’s Institute for Molecular Science (LIMS), a hub of cutting-edge R&D. Here, we met Tim Oldham, CEO and Managing Director of AdAlta, a company pioneering a novel technology platform that engineers key stability features of shark antibodies into human proteins to create unique compounds known as i-bodies, which are designed for therapeutic intervention in disease, with an initial focus on treating fibrotic diseases. Day 04 was a testament to the groundbreaking work happening in Melbourne, where science and innovation are driving the future of healthcare. Stay with us as we continue our journey across Australia, uncovering the advancements that are changing lives.